Press Releases

Latest

AstraZeneca amends collaboration with Ironwood for Linzess in China
18 September 2019
AstraZeneca redefines cancer treatment with practice-changing data at ESMO 2019
16 September 2019
FDA grants Fast Track designation for Farxiga in heart failure
16 September 2019
Imfinzi is first immunotherapy to show both significant survival benefit and improved, durable responses in extensive-stage small cell lung cancer
9 September 2019
Tagrisso approved in China as a 1st-line treatment for EGFR-mutated non-small cell lung cancer
4 September 2019
Brilinta reduced the risk of cardiovascular events in patients with coronary artery disease and type-2 diabetes in Phase III THEMIS trial
1 September 2019
Detailed results from Phase III DAPA-HF trial showed Farxiga significantly reduced both the incidence of cardiovascular death and the worsening of heart failure
1 September 2019
AstraZeneca to present data at ESC Congress 2019 that potentially redefine the treatment of heart failure
29 August 2019
Anifrolumab Phase III trial meets primary endpoint in systemic lupus erythematosus
29 August 2019
Fasenra granted US Orphan Drug Designation for eosinophilic oesophagitis
28 August 2019

Can't find what you are looking for? Our Press Release archive contains all of our press releases dated before 2018 so you should be able to find just what you are looking for.

Explore archive

Contact us

Gonzalo Viña

Head of Global Media Relations

+44 203 749 5916

Rob Skelding

Director Global Media Relations

+44 203 749 5821

Matthew Kent

Director Global Media Relations

+44 203 749 5906

Rebecca Einhorn

Director Global Media Relations

+1 301 398 1802

Jennifer Hursit

Manager Global Media Relations

+442037495762

Christina Malmberg Hägerstrand

Media Relations Director, Sweden and Nordic-Baltic

+46 8 552 53 106

Lotta Sjösten

Manager Media Relations, Sweden

+46 8 553 271 10

US Media Team

+1 302 885 2677

Press Releases

Contact us

Subscribe

Follow us

LinkedIn